
Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022 Including: 1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Others 2) By Application: Academic Research; Drug Development And Discovery; Toxicity Screening; R
Description
Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global induced pluripotent stem cell (ipsc) market.
The report focuses on the induced pluripotent stem cell (ipsc) market which is experiencing strong growth. The report gives a guide to the induced pluripotent stem cell (ipsc) market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemicReasons to Purchase
Where is the largest and fastest growing market for the induced pluripotent stem cell (ipsc)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Induced Pluripotent Stem Cell (iPSC) Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered: 1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Others
2) By Application: Academic Research; Drug Development And Discovery; Toxicity Screening; Regenerative Medicine
3) By End-User: Hospitals; Research Laboratories
Companies Mentioned: Thermo Fisher Scientific Inc.; FUJIFILM Holdings Corporation (Cellular Dynamics); Takara Bio Inc.; Astellas Pharma Inc.; Fate Therapeutics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
Thermo Fisher Scientific Inc.; FUJIFILM Holdings Corporation (Cellular Dynamics); Takara Bio Inc.; Astellas Pharma Inc.; Fate Therapeutics; ViaCyte; StemCells; Japan Tissue Engineering Co. Ltd.; Fate Therapeutics; Japan Tissue Engineering Co.; Ncardia; Axol Bioscience; ORIG3N; Lonza; REPROCELL; BRISTOL-MYERS SQUIBB (IPIERIAN); VIACYTE INC.; ABM (APPLIED BIOLOGICAL MATERIALS INC.); ADDGENE; ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC.; ALSTEM LLC; APPLIED STEMCELL INC.; ATCC; AXIOGENESIS AG; AXOL BIOSCIENCEE; BIO-TECHNE; BLUEROCK THERAPEUTICS; GENTARGET INC.; ID PHARMA CO. LTD.; INVIVOGEN
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
The report focuses on the induced pluripotent stem cell (ipsc) market which is experiencing strong growth. The report gives a guide to the induced pluripotent stem cell (ipsc) market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemicReasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Where is the largest and fastest growing market for the induced pluripotent stem cell (ipsc)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Induced Pluripotent Stem Cell (iPSC) Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The Market Characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered: 1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Others
2) By Application: Academic Research; Drug Development And Discovery; Toxicity Screening; Regenerative Medicine
3) By End-User: Hospitals; Research Laboratories
Companies Mentioned: Thermo Fisher Scientific Inc.; FUJIFILM Holdings Corporation (Cellular Dynamics); Takara Bio Inc.; Astellas Pharma Inc.; Fate Therapeutics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
Thermo Fisher Scientific Inc.; FUJIFILM Holdings Corporation (Cellular Dynamics); Takara Bio Inc.; Astellas Pharma Inc.; Fate Therapeutics; ViaCyte; StemCells; Japan Tissue Engineering Co. Ltd.; Fate Therapeutics; Japan Tissue Engineering Co.; Ncardia; Axol Bioscience; ORIG3N; Lonza; REPROCELL; BRISTOL-MYERS SQUIBB (IPIERIAN); VIACYTE INC.; ABM (APPLIED BIOLOGICAL MATERIALS INC.); ADDGENE; ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC.; ALSTEM LLC; APPLIED STEMCELL INC.; ATCC; AXIOGENESIS AG; AXOL BIOSCIENCEE; BIO-TECHNE; BLUEROCK THERAPEUTICS; GENTARGET INC.; ID PHARMA CO. LTD.; INVIVOGEN
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Induced Pluripotent Stem Cell (iPSC) Market Characteristics
- 3. Induced Pluripotent Stem Cell (iPSC) Market Trends And Strategies
- 4. Impact Of COVID-19 On Induced Pluripotent Stem Cell (iPSC)
- 5. Induced Pluripotent Stem Cell (iPSC) Market Size And Growth
- 5.1. Global Induced Pluripotent Stem Cell (iPSC) Historic Market, 2016-2021, $ Billion
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints On The Market
- 5.2. Global Induced Pluripotent Stem Cell (iPSC) Forecast Market, 2021-2026F, 2031F, $ Billion
- 5.2.1. Drivers Of The Market
- 5.2.2. Restraints On the Market
- 6. Induced Pluripotent Stem Cell (iPSC) Market Segmentation
- 6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Hepatocytes
- Fibroblasts
- Keratinocytes
- Amniotic Cells
- Others
- 6.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Academic Research
- Drug Development And Discovery
- Toxicity Screening
- Regenerative Medicine
- 6.3. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Hospitals
- Research Laboratories
- 7. Induced Pluripotent Stem Cell (iPSC) Market Regional And Country Analysis
- 7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 7.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 8. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market
- 8.1. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 8.3. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 9. China Induced Pluripotent Stem Cell (iPSC) Market
- 9.1. China Induced Pluripotent Stem Cell (iPSC) Market Overview
- 9.2. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
- 9.3. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
- 10. India Induced Pluripotent Stem Cell (iPSC) Market
- 10.1. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 10.2. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 11. Japan Induced Pluripotent Stem Cell (iPSC) Market
- 11.1. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 11.2. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 12. Australia Induced Pluripotent Stem Cell (iPSC) Market
- 12.1. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 12.2. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 13. Indonesia Induced Pluripotent Stem Cell (iPSC) Market
- 13.1. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 13.2. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 14. South Korea Induced Pluripotent Stem Cell (iPSC) Market
- 14.1. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 14.2. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 15. Western Europe Induced Pluripotent Stem Cell (iPSC) Market
- 15.1. Western Europe Induced Pluripotent Stem Cell (iPSC) Market Overview
- 15.2. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 15.3. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 16. UK Induced Pluripotent Stem Cell (iPSC) Market
- 16.1. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 16.2. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 17. Germany Induced Pluripotent Stem Cell (iPSC) Market
- 17.1. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 17.2. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 18. France Induced Pluripotent Stem Cell (iPSC) Market
- 18.4. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 18.5. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 19. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market
- 19.1. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market Overview
- 19.2. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 19.3. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 20. Russia Induced Pluripotent Stem Cell (iPSC) Market
- 20.1. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 20.2. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 21. North America Induced Pluripotent Stem Cell (iPSC) Market
- 21.1. North America Induced Pluripotent Stem Cell (iPSC) Market Overview
- 21.2. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 21.3. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 22. USA Induced Pluripotent Stem Cell (iPSC) Market
- 22.1. USA Induced Pluripotent Stem Cell (iPSC) Market Overview
- 22.2. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 22.3. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 23. South America Induced Pluripotent Stem Cell (iPSC) Market
- 23.1. South America Induced Pluripotent Stem Cell (iPSC) Market Overview
- 23.2. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 23.3. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 24. Brazil Induced Pluripotent Stem Cell (iPSC) Market
- 24.1. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 24.2. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 25. Middle East Induced Pluripotent Stem Cell (iPSC) Market
- 25.1. Middle East Induced Pluripotent Stem Cell (iPSC) Market Overview
- 25.2. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 25.3. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 26. Africa Induced Pluripotent Stem Cell (iPSC) Market
- 26.1. Africa Induced Pluripotent Stem Cell (iPSC) Market Overview
- 26.2. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 26.3. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 27. Induced Pluripotent Stem Cell (iPSC) Market Competitive Landscape And Company Profiles
- 27.1. Induced Pluripotent Stem Cell (iPSC) Market Competitive Landscape
- 27.2. Induced Pluripotent Stem Cell (iPSC) Market Company Profiles
- 27.2.1. Thermo Fisher Scientific Inc.
- 27.2.1.1. Overview
- 27.2.1.2. Products and Services
- 27.2.1.3. Strategy
- 27.2.1.4. Financial Performance
- 27.2.2. FUJIFILM Holdings Corporation (Cellular Dynamics)
- 27.2.2.1. Overview
- 27.2.2.2. Products and Services
- 27.2.2.3. Strategy
- 27.2.2.4. Financial Performance
- 27.2.3. Takara Bio Inc.
- 27.2.3.1. Overview
- 27.2.3.2. Products and Services
- 27.2.3.3. Strategy
- 27.2.3.4. Financial Performance
- 27.2.4. Astellas Pharma Inc.
- 27.2.4.1. Overview
- 27.2.4.2. Products and Services
- 27.2.4.3. Strategy
- 27.2.4.4. Financial Performance
- 27.2.5. Fate Therapeutics
- 27.2.5.1. Overview
- 27.2.5.2. Products and Services
- 27.2.5.3. Strategy
- 27.2.5.4. Financial Performance
- 28. Key Mergers And Acquisitions In The Induced Pluripotent Stem Cell (iPSC) Market
- 29. Induced Pluripotent Stem Cell (iPSC) Market Future Outlook and Potential Analysis
- 30. Appendix
- 30.1. Abbreviations
- 30.2. Currencies
- 30.3. Research Inquiries
- 30.4. The Business Research Company
- 30.5. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.